AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
New data from telisotuzumab adizutecan (Temab-A) and ABBV-706 across pancreatic, colorectal, and solid tumors, highlight progress in AbbVie’s growing ADC... Read more.
General Dynamics Land Systems and Parry Labs Partner to Advance Digital Integration for Combat Systems
Strategic teaming agreement leverages complementary strengths to deliver secure, flexible, and rapidly updatable solutions for Army modernization ALEXANDRIA, Va.,... Read more.
Housecall Pro launches Electrical Toolkit app, enhancing jobsite efficiency
The trusted provider of field service management software announces new, all-in-one solution designed with electricians and electrical contractors in mind SAN DIEGO,... Read more.
Reins CEO Chris Buttenham to speak at Service World Expo 2025
The leading expert in alternative equity solutions for the skilled trades will share insights and best practices to support employee retention LAS VEGAS, Oct. 13,... Read more.
World’s Largest AI-in-Projects Study Reveals: Artificial Intelligence Is Revolutionizing How $48 Trillion in Projects Are Delivered
The 2025 Global AIPM Survey, the most comprehensive study of its kind, shows that organizations using AI are executing projects up to 25% faster and achieving measurable... Read more.
Daqo New Energy to Announce Unaudited Results for the Third Quarter of 2025 on October 27, 2025
SHANGHAI, Oct. 13, 2025 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) (“Daqo New Energy” or the “Company”), a leading manufacturer... Read more.
Hughes and Gogo Celebrate Key FDX and HDX Aviation ESA Milestones
Hughes and Gogo Partnership continues to transform in-flight connectivity with the on-time arrival of HDX and FDX ESAs GERMANTOWN, Md., Oct. 13, 2025 /PRNewswire/... Read more.
Discover how Developments in Technology and Preventative Solutions are Driving Change
Tune in to Bloomberg TV to watch Advancements on Saturday, October 18th at 8:00 pm ET. JUPITER, Fla., Oct. 13, 2025 /PRNewswire/ — A new episode of Advancements... Read more.
Compugen to Present Pooled Analysis of COM701 in Three Phase 1 Trials in Patients with Platinum Resistant Ovarian Cancer at ESMO 2025
Pooled analysis supports the rationale for the ongoing MAIA-ovarian trial evaluating COM701 as maintenance therapy in the earlier setting of platinum sensitive ovarian... Read more.
Nanoscope Therapeutics Announces Multiple Presentations at the American Academy of Ophthalmology 2025 Annual Meeting
DALLAS, Oct. 13, 2025 /PRNewswire/ — Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel disease-agnostic... Read more.